Anti-Human ITGA2B & ITGB3 Recombinant Antibody(Abciximab)
-
产品编号
YR1084
-
别名
科研级 Abciximab ( 阿昔单抗 ), Anti-ITGA2B & ITGB3 Recombinant Antibody, Research Grade Abciximab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1084 |
| Alias | 科研级 Abciximab ( 阿昔单抗 ), Anti-ITGA2B & ITGB3 Recombinant Antibody, Research Grade Abciximab |
| Size | 1mg, 5mg |
| Molecular Name | Abciximab |
| CAS Number | 143653-53-6 |
| Molecular Weight | 145.65 kDa |
| Target | ITGA2B & ITGB3[Homo sapiens] |
| Antibody Isotype | Fab-G1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitionitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. |
| Application | ELISA, IHC, IF, IP, FCM, FuncS |
| Remarks | This product is for research use only. |
0